AstraZeneca plans to delist from Nasdaq and move to the NYSE, while its breast cancer drug Enhertu enters European regulatory ...

AstraZeneca on Tuesday said it would delist its American Depositary Shares and debt securities from Nasdaq and complete a ...

AstraZeneca (NASDAQ:AZN) has announced it will shift its US listing from Nasdaq to the New York Stock Exchange, delisting its ...

The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...

Anglo-Swedish pharma major AstraZeneca has provided notice of its withdrawal from listing of its American Depositary Shares ...

Investing.com - Guggenheim has reiterated its Buy rating on AstraZeneca (NASDAQ:AZN) (AZN:LN) with a price target of ...

London: British pharmaceutical giant AstraZeneca on Tuesday said trading of its shares on the New York Stock Exchange will start from February, in ...

January 2026 AstraZeneca to complete direct listing of ordinary shares and all US debt securities on the New York Stock ExchangeTicker symbol for ordinary shares will remain AZN AstraZeneca PLC ("Astr ...

Walmart (WMT) stock joins the Nasdaq-100 on Jan. 20, 2026, replacing AstraZeneca (AZN) stock—potentially driving $19B in ...

AstraZeneca (NASDAQ: AZN) is one of the best future stocks to buy for the long term. On January 6, Barclays analyst James ...

That morning, U.K. newspaper The Times published an article stating that AstraZeneca CEO Pascal Soriot aims to move the company's stock market listing onto our shores (ADSes are certificates ...